文献速递临床试验与 GCP

阴道分娩皮肤消毒剂(SAVE)试验:一项随机对照试验的研究方案

The Skin Antiseptic agents at Vaginal dElivery (SAVE) trial: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2023-02-21

本研究为多中心随机对照试验,纳入计划阴道分娩并在会阴切开术后分娩的足月孕妇,随机分配至聚维酮碘或氯己定-酒精进行会阴消毒。主要结局为阴道分娩后30天内浅表或深部会阴伤口感染,次要结局包括住院时长、因感染相关并发症就诊或再入院、子宫内膜炎、皮肤刺激及过敏反应。该研究旨在确定预防会阴伤口感染的最佳消毒剂。

要点

  • 多中心随机对照试验比较氯己定-酒精与聚维酮碘用于会阴消毒。
  • 纳入计划阴道分娩并在会阴切开术后分娩的足月孕妇。
  • 主要结局为分娩后30天内浅表或深部会阴伤口感染。

核心结论

  • 本研究将是首个旨在确定阴道分娩后会阴伤口感染预防最佳消毒剂的随机对照试验。

研究设计与样本

  • 多中心随机对照试验,纳入计划阴道分娩并在会阴切开术后分娩的足月孕妇,随机分配至聚维酮碘或氯己定-酒精进行会阴消毒。

关键数值与推荐

  • 主要结局为阴道分娩后30天内浅表或深部会阴伤口感染。
  • 次要结局为住院时长、因感染相关并发症的医生就诊或医院再入院、子宫内膜炎、皮肤刺激及过敏反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cleansing of the vulva and perineum is recommended during preparation for vaginal delivery, and special attention is paid to cleansing before episiotomy because episiotomy is known to increase the risk of perineal wound infection and/or dehiscence. However, the optimal method of perineal cleansing has not been established, including the choice of antiseptic agent. To address this issue, we designed a randomized controlled trial to examine whether skin preparation with chlorhexidine-alcohol is superior to povidone-iodine for the prevention of perineal wound infection after vaginal delivery. METHODS: In this multicenter randomized controlled trial, term pregnant women who plan to deliver vaginally after episiotomy will be enrolled. The participants will be randomly assigned to use antiseptic agents for perineal cleansing (povidone-iodine or chlorhexidine-alcohol). The primary outcome is superficial or deep perineal wound infection within 30 days after vaginal delivery. The secondary outcomes are the length of hospital stay, physician office visits, or hospital readmission for infection-related complications, endometritis, skin irritations, and allergic reactions. DISCUSSION: This study will be the first randomized controlled trial aiming to determine the optimal antiseptic agent for the prevention of perineal wound infections after vaginal delivery. TRIAL REGISTRATION: ClinicalTrials.gov NCT05122169. First submitted date on 8 November 2021. First posted date on 16 November 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jung YM, Lee SM, Kim SY, et al. The Skin Antiseptic agents at Vaginal dElivery (SAVE) trial: study protocol for a randomized controlled trial. Trials. 2023. PMID: 36810189. doi:10.1186/s13063-023-07101-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。